Beijing: CanSino Biologics’ top scientist said that its candidate vaccine for Covid-19 is generally safe and effective, reassuring investors after clinical trials for the same type of vaccine developed in the United Kingdom were paused when a participant was suspected of having a life-threatening adverse reaction.
On Wednesday, the Phase 3 clinical trials for the UK vaccine, developed by Oxford University and biotech company AstraZeneca, were shut down across the globe after a woman in the UK trial experienced symptoms similar to a rare but serious spinal cord inflammatory disorder called transverse myelitis, according to United States medical news website Stat News.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
